Search Results - "Murakami, Maryann"

Refine Results
  1. 1

    Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population by APPLE, Fred S, LER, Ranka, MURAKAMI, Maryann M

    Published in Clinical chemistry (Baltimore, Md.) (01-11-2012)
    “…Between-assay comparability of 99th percentiles for cardiac troponin concentrations has not been assessed systematically in a single population for a large…”
    Get full text
    Journal Article
  2. 2

    Role of Monitoring Changes in Sensitive Cardiac Troponin I Assay Results for Early Diagnosis of Myocardial Infarction and Prediction of Risk of Adverse Events by Apple, Fred S, Pearce, Lesly A, Smith, Stephen W, Kaczmarek, Jason M, Murakami, MaryAnn M

    Published in Clinical chemistry (Baltimore, Md.) (01-05-2009)
    “…We sought to determine the diagnostic accuracy of the cardiac troponin I (cTnI) VITROS(R) Troponin I-ES assay for early detection of acute myocardial…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Use of the Centaur TnI-Ultra Assay for Detection of Myocardial Infarction and Adverse Events in Patients Presenting With Symptoms Suggestive of Acute Coronary Syndrome by Apple, Fred S, Smith, Stephen W, Pearce, Lesly A, Ler, Ranka, Murakami, MaryAnn M

    Published in Clinical chemistry (Baltimore, Md.) (01-04-2008)
    “…We determined the diagnostic accuracy of the Advia Centaur TnI-Ultra assay for detecting myocardial infarction (MI) and assessing risk of adverse events in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction by Palamalai, Vikram, Murakami, MaryAnn M., Apple, Fred S.

    Published in Clinical biochemistry (01-11-2013)
    “…This study evaluated the diagnostic performance of four point-of-care (POC) cardiac troponin I (cTnI) assays compared to a central laboratory cTnI assay for…”
    Get full text
    Journal Article
  7. 7

    Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay by Apple, Fred S., Simpson, Peter A., Murakami, MaryAnn M.

    Published in Clinical biochemistry (01-08-2010)
    “…This study determined the serum 99th percentile reference value for cTnI measured using the high sensitivity Erenna® cTnI assay. Serum was obtained from…”
    Get full text
    Journal Article
  8. 8

    Increased Cardiac Troponin I As Measured by a High-Sensitivity Assay Is Associated with High Odds of Cardiovascular Death: The Minnesota Heart Survey by APPLE, Fred S, STEFFEN, Lyn M, PEARCE, Lesly A, MURAKAMI, Maryann M, LUEPKER, Russell V

    Published in Clinical chemistry (Baltimore, Md.) (01-05-2012)
    “…We examined several novel biomarkers of different pathophysiologic pathways as predictors of cardiovascular mortality in participants enrolled in the Minnesota…”
    Get full text
    Journal Article
  9. 9

    Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk by Sandoval, Yader, Thordsen, Sarah E, Smith, Stephen W, Schulz, Karen M, Murakami, MaryAnn M, Pearce, Lesly A, Apple, Fred S

    “…Aims: To determine the ability of serial cardiac troponin (cTnI) changes (delta) to distinguish type 1 and type 2 myocardial infarction (MI) (excluding all…”
    Get full text
    Journal Article
  10. 10

    GENDER DIFFERENCES IN MORTALITY AMONG PATIENTS WITH SUPPLY-DEMAND TYPE 2 MYOCARDIAL INFARCTION, TYPE 1 MYOCARDIAL INFARCTION AND NON-MI CARDIAC TROPONIN I INCREASES by Sandoval, Yader, Thordsen, Sarah, Smith, Stephen, Murakami, MaryAnn M, Schulz, Karen, Apple, Fred

    “…In-hospital mortality and post-discharge mortality in men was 5% and 9% in T1MI, 9% and 17% in T2MI, 12% and 16% in non-MI cTnI increases, and 2% and 5% in no…”
    Get full text
    Journal Article
  11. 11

    Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease by APPLE, Fred S, MURAKAMI, Maryann M, PEARCE, Lesly A, HERZOG, Charles A

    Published in Circulation (New York, N.Y.) (03-12-2002)
    “…This study determined the prevalence of increased cardiac troponin I (cTnI) and T (cTnT) in end-stage renal disease (ESRD) patients and whether an increased…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Assessment of the Multiple-Biomarker Approach for Diagnosis of Myocardial Infarction in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome by Apple, Fred S, Smith, Stephen W, Pearce, Lesly A, Murakami, MaryAnn M

    Published in Clinical chemistry (Baltimore, Md.) (01-01-2009)
    “…Cardiac troponin is the preferred biomarker for detecting acute myocardial injury and infarction (MI). We studied whether multiple biomarkers of numerous…”
    Get full text
    Journal Article
  14. 14

    Immunodetection of Glycosylated NT-proBNP Circulating in Human Blood by Seferian, Karina R, Tamm, Natalia N, Semenov, Alexander G, Tolstaya, Anastasia A, Koshkina, Ekaterina V, Krasnoselsky, Mihail I, Postnikov, Alexander B, Serebryanaya, Daria V, Apple, Fred S, Murakami, MaryAnn M, Katrukha, Alexey G

    Published in Clinical chemistry (Baltimore, Md.) (01-05-2008)
    “…Brain natriuretic peptide (BNP) or NT-proBNP (N-terminal fragment of BNP precursor) measurements are recommended as aids in diagnosis and prognosis of patients…”
    Get full text
    Journal Article
  15. 15

    Multiple Biomarker Use for Detection of Adverse Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome by Apple, Fred S, Pearce, Lesly A, Chung, Adrine, Ler, Ranka, Murakami, MaryAnn M

    Published in Clinical chemistry (Baltimore, Md.) (01-05-2007)
    “…We investigated multiple biomarkers of various pathophysiologic pathways to determine their relationships with adverse outcomes in patients presenting with…”
    Get full text
    Journal Article
  16. 16

    Electronic medical record-based performance improvement project to document and reduce excessive cardiac troponin testing by Love, Sara A, McKinney, Zeke J, Sandoval, Yader, Smith, Stephen W, Kohler, Rebecca, Murakami, MaryAnn M, Apple, Fred S

    Published in Clinical chemistry (Baltimore, Md.) (01-03-2015)
    “…We assessed the utilization rationale behind provider ordering of cardiac troponin I (cTnI) testing for the diagnosis of myocardial infarction after…”
    Get full text
    Journal Article
  17. 17

    Performance characteristics of the ARCHITECT Galectin-3 assay by La'ulu, Sonia L., Apple, Fred S., Murakami, MaryAnn M., Ler, Ranka, Roberts, William L., Straseski, Joely A.

    Published in Clinical biochemistry (01-01-2013)
    “…Galectin-3 is an emerging biomarker that is commonly increased in patients with heart failure and/or patients at risk for cardiovascular disease. We evaluated…”
    Get full text
    Journal Article
  18. 18

    Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay by Apple, Fred S., Smith, Stephen W., Pearce, Lesly A., Murakami, MaryAnn M.

    Published in Clinical biochemistry (01-07-2012)
    “…We determined diagnostic accuracy and risk stratification using delta changes for the cardiac troponin I (cTnI) Centaur Ultra assay for ruling out acute…”
    Get full text
    Journal Article
  19. 19

    Cardiac troponin testing is overused after the rule-in or rule-out of myocardial infarction by Fraga, Olaia Rodriguez, Sandoval, Yader, Love, Sara A, McKinney, Zeke J, Murakami, MaryAnn M, Smith, Stephen W, Apple, Fred S

    Published in Clinical chemistry (Baltimore, Md.) (01-02-2015)
    “…After receiving institutional review board approval, we retrospectively reviewed electronic health/ medical records in 100 consecutive patients who had serial…”
    Get full text
    Journal Article
  20. 20